切片设备的全球市场 - 产业分析及市场预测(2017年～2022年)

切片设备的全球市场，2014年估量为16亿美元，预计从2014年2021年的预测期间将以7.1％的年复合成长率成长，到2020年达到24亿1,400万美元的规模。切片检查，判断检查组织或细胞受到影响的组织，并从体内除去。进行做如果采为了有患者癌症的疑问，诊断及癌症判断组织样品切片检查。这个程序，为了查出癌症由介入性放射学者进行。这个市场终端用户，是医院，诊断中心，及其他的诊疗所。

本报告提供全球切片设备市场调查，整体市场趋势，各产品、地区的详细趋势，市场成长的影响要素分析，竞争情形，主要企业简介等，总括性汇整。

目录

第1章 简介

• 关于报告
• 调查方法
• 相关利益者

第2章 摘要整理

• 主要的觀察
• 市场概要

第3章 市场概况

• 市场定义
  • 简介
  • 切片检查定义
  • 切片检查为何进行？
  • 切片检查识别症状的条件
  • 切片检查的类型
• 市场成长要素
  • 一般认识的提高
  • 癌症人口的增加
  • 筛检检验的增加
  • 新兴市场
• 市场阻碍因素
  • 设备成本

第4章 全球市场:各设备类型市场区隔

• 针头
• 刮匙
• 打洞器
• 钳子
• 喷枪
• 自动切片设备

第5章 全球市场:各地理市场区隔

• 北美
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 法国
  • 德国
  • 西班牙
• 亚太地区
  • 中国
  • 韩国
  • 印度
  • 日本
• 其他地区
  • 巴西
  • 中东
  • 澳洲

第6章 竞争情形

• 简介
• M&A
• 扩张
• 新产品的销售
• 合作

第7章 企业简介

• CR Bard
• Hologic
• Carefusion
• Devicor Medical Products
• Cook Medical
• Boston Scientific
• Intact Medical Corporation
• Gallini Medical Devices
• TSK Laboratory

The Biopsy Devices Market is expected to register a CAGR of 6.8% during the forecast period. The propelling factors for the growth of the biopsy devices market include the increasing preference for minimally invasive procedures, an increase in the number of cancer cases worldwide, and initiatives undertaken by the government for diagnosis.

Biopsy has been one of the major diagnosis techniques for cancer disorders and is widely used in the diagnosis of breast, skin, and prostate cancer. According to the World Cancer Report, cancer rates could further increase by 50% to 15 million new cases by 2020. Therefore, with the increasing incidence of cancer cases and developments in the biopsy devices, the market is expected to increase in the forecast period.

There is also a demand for minimally invasive biopsy procedures that is rising at a significant rate in the market. The different types of technologies and products, such as biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices are anticipated to witness the high growth during the forecast period.

In addition, the growing awareness regarding breast cancer treatment and diagnosis will support the increase in the biopsy devices market size in the upcoming years. There are many countries that hold programs for the early diagnosis of breast cancer. Therefore, such initiatives will accelerate the adoption rate of biopsy devices, thereby positively impacting the growth of the biopsy devices business in the foreseeable future.

Key Market Trends

Needle-based Biopsy Instruments is is Expected to Hold a Major Market Share in the Biopsy Devices Market

Needle-based biopsy holds the leading share in the market due to the increasing demand for these instruments, for acquiring samples from soft tissues of internal organs, such as breasts, kidneys, and lungs. This is poised to contribute to the growth of the overall market during the forecast period.

According to the National Cancer Institute (NCI), in 2019, it was estimated that there were 61,780 cases of leukaemia and an estimated 22,840 people died due to leukaemia in the United States in 2019. Hence, the above benefits of needle-based biopsy guns coupled with the increasing demand for minimally invasive procedures will spur the segmental growth.

North America Holds the Largest Share and is Expected to Follow the Same Trend Over the Forecast Period

North America is found to be the leading revenue contributor in the market. The established market players in the region will continue to account for a substantial share in the market throughout the forecast period. The number of biopsies performed in the United States is also found to be the highest, helping in the expansion of the overall market. As per the American Cancer Society's 2020 report, estimates that about 60,530 new cases of leukemia and approximately 23,100 deaths from leukemia are expected to occur in the United States in 2020. Furthermore, sophisticated healthcare infrastructure and the growing prevalence of infections will positively impact the biopsy devices growth over the projected timeframe.

Competitive Landscape

The Biopsy Devices Market is fragmented competitive. The major market players operating in the biopsy devices market are Hologic, C.R. Bard Inc., Devicor Medical Products Inc., among other players. These companies are undertaking strategies, such as product launch through technological innovations and partnerships to gain profits in the industry. Thus, the new product launches are the most preferred strategy followed by collaborations and geographical expansion for market capitalization.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Preference for Minimally Invasive Procedures
  • 4.2.2 Increase in the Number of Cancer Cases Worldwide
  • 4.2.3 Initiatives Undertaken by Government for Diagnosis
• 4.3 Market Restraints
  • 4.3.1 Product Recalls
  • 4.3.2 Availability of Alternative Techniques
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Product
  • 5.1.1 Needle-based Biopsy Instruments
    • 5.1.1.1 Core Biopsy Devices
    • 5.1.1.2 Aspiration Biopsy Needles
    • 5.1.1.3 Vacuum-assisted Biopsy Devices
  • 5.1.2 Procedure Trays
  • 5.1.3 Localization Wires
  • 5.1.4 Other Products
• 5.2 By Application
  • 5.2.1 Breast Biopsy
  • 5.2.2 Lung Biopsy
  • 5.2.3 Colorectal Biopsy
  • 5.2.4 Prostate Biopsy
  • 5.2.5 Other Applications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East & Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East & Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Becton, Dickinson and Company
  • 6.1.2 Hologic Inc.
  • 6.1.3 Devicor Medical Products Inc.
  • 6.1.4 Cook Medical
  • 6.1.5 Boston Scientific Corporation
  • 6.1.6 Intact Medical Corporation
  • 6.1.7 Gallini Medical
  • 6.1.8 TSK Laboratory Europe BV
  • 6.1.9 Argon Medical Devices

7 MARKET OPPORTUNITIES AND FUTURE TRENDS